Prevention of coronary heart disease and cancer by tea, a review

Environmental Health and Preventive Medicine

Volumn 7, Issue 6, 2003, Pages 283-288

  Weisburger, John H ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Angiogenesis; Apoptosis; Bacterial flora; Black and green tea; Cancer; Cell growth inhibition; Extended aging; Heart disease; Prevention; Reactive oxygen species

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2B1; DNA; EPIGALLOCATECHIN GALLATE; GLUCURONOSYLTRANSFERASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYPHENOL; REACTIVE OXYGEN METABOLITE; THEAFLAVIN;

AGING; ANGIOGENESIS; APOPTOSIS; CANCER; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CELL GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME INDUCTION; GROWTH INHIBITION; HUMAN; INTESTINE FLORA; ISCHEMIC HEART DISEASE; META ANALYSIS; REVIEW; TEA;

BACTERIA (MICROORGANISMS); CAMELLIA SINENSIS;

EID: 0037276483     PISSN: 1342078X     EISSN: None     Source Type: Journal    
DOI: 10.1265/ehpm.2003.283     Document Type: Review

References (85)

1. Weisburger JH. Tea. In: Kipple, K, Omelas, K.C. editors. The Cambridge World History of Food. Vol 1, (Cambridge, UK; Cambridge University Press, 2000: 712-720.
2. Wiseman SA, Balentine DA, Frei B. Antioxidants in tea. Crit. Rev. Food Sci. Nutr. 1997; 37: 705-718.
3. Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, Packer L. Factors associated with oxidative stress in human populations. Am. J. Epidemiol. 2002; 156: 274-285.
4. Halliwell B. Effect of diet on cancer development: is oxidative DNA damage a biomarker? Free Rad. Biol. Med. 2002; 32: 968-974.
5. Katiyar SK, Afaq F, Perez A, Mukhtar H. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis 2001; 22: 287-294.
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989; 320: 915-924.
7. Vinson JA. Black and green tea and heart disease: A review. Biofactors 2000; 13: 127-132.
8. Weisburger JH, Hosey JR, Larios E, Pittman B, Zang E, Hara Y, Kuts-Cheraux G. Investigation of commercial MitoLife as an antioxidant and antimutagen. Nutrition 2001; 17: 322-325.
9. Geleijnse JM, Launer LJ, Hofman A, Pols HAP, Witteman JCM. Tea flavonoids may protect against atherosclerosis: The Rotterdam Study. Arch. Intern. Med. 1999; 159: 2170-2174.
10. Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am. J. Clin. Nutr. 2002; 75: 880-886.
11. Arts ICW, Hollman PCH, Feskens EJM, Bueno de Mesquita H, Kromhout D. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am. J. Clin. Nutr. 2001; 74: 227-232.
12. Ishikawa T, Suzukawa M, Ito T, Yoshida H, Ayaori M, Nishiwaki M, Yonemura A, Hara Y, Nakamura H. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am. J. Clin Nutr. 1997; 66: 261-266.
13. Hertog MG, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am. J. Clin. Nutr. 1997; 65: 1542-1543.
14. Tokunaga S, White IR, Frost C, Tanaka K, Kono S, Tokudome S, Akamatsu T, Moriyama T, Zakouji H. Green tea consumption and serum lipids and lipoproteins in n a population of healthy workers in Japan. Ann. Epidemiol. 2002; 12: 157-165.
15. Sesso HD, Gaziano JM, Buring JE, Hennekens CH. Coffee and tea intake and the risk of myocardial infarction. Am. J. Epidmiol. 1999; 149: 162-167.
16. Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am. J. Epidemiol. 2001; 154: 495-503.
17. Nakachi K, Matsuyama S, Mikake S, Suganuma M, Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 2000; 13: 49-54.
18. Hodgson JM, Puddey IB, Burke V, Beilin LJ, Mori TA, Chan SY. Acute effects of ingestion of black tea on postprandial platelet aggregation in human subjects. Br. J. Nutr. 2002; 87: 141-145.
19. Duffy SJ, Keaney JF Jr, Hollbrook M, Gokce N, Swerdloff PL, Frei B, Vita JA. Short-and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001; 104: 151-156.
20. Wolfram RM, Oguogho A, Efthimiou Y, Budinsky AC, Sinzinger H. Effect of black tea on (iso-)prostaglandins and platelet aggregation in healthy volunteers. Prostaglandins Leukot Essent Fatty Acids 2002; 66: 529-533.
21. Duffy SJ, Vita JA Holbrook M, Swerdloff PL, Keaney JF Jr. Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Bas. Biol. 2002; 21: 1084-1089.
22. Kono S, Ikeda M, Tokudome S, Kuratsune M. A case-control study of gastric cancer and diet in Northern Kyushu, Japan. Jpn. J. Cancer Res. 1988; 79: 1067-1074.
23. Weisburger JH, Williams GM. The distinction between genotoxic and epigenetic carcinogens and implication for cancer risk. Toxicol. Sci. 2000; 57: 4-5.
24. Weisburger JH, Hara Y, Dolan L, Luo F-Q, Pittman B, Zang, E. Tea polyphenols as inhibitors of mutagenicity of major classes of carcinogens. Mutation Res. 1996; 371: 57-63.
25. Kuroda Y, Hara Y. Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat. Res. 1999; 436: 69-97.
26. Rogers AE, Hafer LJ, Iskander YS, Yang S. Black tea and mammary gland carcinogenesis by 7,12-dimethylbenz[a]anthracene in rats fed control or high fat diets. Carcinogenesis 1998; 19: 1269-1273.
27. Weisburger JH, Rivenson A, Garr K, Aliaga C. Tea, or tea and milk, inhibit mammary gland and colon carcinogenesis. Cancer Lett. 1997; 114: 323-327.
28. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 2002; 42: 25-54.
29. Mukhtar H, Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am. J. Clin. Nutr. 2000; 71: 1698S-1702S.
30. Wang Zy, Wang LD, Lee MJ, Ho CT, Huang MT, Conney AH, Yang CS. Inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats by green and black tea. Carcinogenesis 1995; 16: 2143-1248.
31. Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JJ. Reduced risk of esophageal cancer associated with green tea consumption. J. Natl. Cancer Inst. 1994; 86: 855-858.
32. Weisburger JH, Chung F-L. Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. Food Chem. Toxicol. 2002; 40: 1145-1154.
33. Nagao M, Sugimura T (eds). Food Borne Carcinogens: Heterocyclic Amines. Chichester, NY: John Wiley & Sons, LTD, 2000, pp. 1-373.
34. Felton JS, Knize MG, Salmon CP, Malfatti MA, Kulp KS. Human exposure to heterocyclic amine food mutagens/carcinogens: relevance to breast cancer. Env. Mol. Mutag. 2002; 39: 112-118.
35. Sinha R, Kulldorff M, Chow WH, Denobile J, Rothman N. Dietary intake of heterocyclic amines, meat-derived mutagenic activity, and risk of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev. 2001; 10: 559-562.
36. Sinha R, Rothman N. Exposure assessment of heterocyclic amines (HCAs) in epidemiologic studies. Mutation Res. 1997; 376: 195-202.
37. Tanaka T, Barnes WS, Williams GM, Weisburger JH. Multipotential carcinogenicity of the fried food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in rats Japan. J. Cancer Res. 1985; 76: 570-576.
38. Ohgaki H. Carcinogenicity in animals and specific organs. Rodents. In Nagao M, Sugimura T editors. Food-borne Carcinogens: Heterocyclic Amines. New York; Wiley, 2000, p. 198-228.
39. Shirai T, Sano M, Tamano S, Takahashi S, Hirose M, Futakuchi M, Hasegawa, R, Imaida K, Matsumoto K-I, Wakabayashi K, Sugimura T, Ito N. The Prostate: A target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine(PhIP) derived from cooked foods. Cancer Res. 1997; 57: 195-198.
40. Snyderwine EG, Thorgeirsson UP, Venugopal M, Roberts-Thomson SJ. Mammary gland carcinogenicity of 2-aminomethyl-6-phenylimidazo[4,5-fb]pyridine in Sprague Dawley rats on high-and low-fat diets. Nutr. Cancer 1998; 31: 160-167.
41. Bosland MC, McCormick DL, Melamed J, Walden PD, Zeleniuch-Jacquotte A, Lumey LH. Chemoprevention strategies for prostate cancer. Eur. J. Cancer Prev. 2002; 11 (suppl 2): S18-S27.
42. Skog KI, Johansson MA, Jägerstad MI. Carcinogenic heterocyclic amines in model systems and cooked foods: A review on formation, occurrence and intake. Food Chem. Toxicol. 1998; 36: 879-896.
43. Weisburger JH, Dolan L, Pittman B. Inhibition of PhIP mutagenicity by caffeine, lycopene, daidzein, and genistein. Mutation Res. 1998; 416: 125-128.
44. Weisburger JH, Veliath E, Larios E, Pittman B, Zang E, Yukihiko H. Tea polyphenols inhibit the formation of mutagens during the cooking of meat. Mutation Res. 2002; 516: 19-22.
45. Kinae N, Furugori M, Takemura H, Iwazaki M, Shimoi K, Wakabayashi K. Inhibitory effect of tea extracts on the formation of heterocyclic amines during cooking of hamburger. In: Ohigashi, H, Osawa, T, Terao, J, Watanabe, S, Yoshikawa, T editors. Food Factors for Cancer Prevention, Tokyo: Springer, 1997: 142-146.
46. Sohn OS, Surace A, Fiala ES, Richie Jr. JP, Colosimo S, Zang E, Weisburger JH. Effects of green and black tea on hepatic xenobiotic metabolizing systems in the male F344 rat. Xenobiotica 1994; 24: 119-127.
47. Embola CW, Weisburger JH, Weisburger MC. Urinary excretion of N-OH-2-amino-3-methylimidazo[4,5-f]quinoline-N-glucuronide in F344 rats is enhanced by green tea. Carcinogenesis 2001; 22: 1095-1098.
48. Mori H, Yamada Y, Hirose Y, Kuno T, Katayama M, Sakata K, Yoshida K, Sugie S, Hara A, Yoshimi N. Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of β-catenin-accumulated crypts as a new biomarker. Eur. J. Cancer Prev. 2002; 11 (suppl 2): S71-S75.
49. Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem. Pharacol. 2000; 60: 1051-1059.
50. Gupta S, Ahmad N, Nieminen AL, Mukhtar H. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive an androgen-insensitive human prostate carcinoma cells. Toxicol. Appl. Pharmacol. 2000; 164: 82-90.
51. Yang CS, Yang GY, Landau JM, Kim S, Liao J. Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression. Exp. Lung Res. 1998; 24: 629-639.
52. Uesato S, Kitagawa Y, Kamishimoto M, Kumagai A, Hori H. Inhibition of green tea catechins against the growth of cancerous human colon and hepatic epithelial cells. Cancer Lett. 2001; 170: 41-44.
53. Jung YD, Kim MS, Shin BA, Chay KO, Ahn BW, Liu W, Bucana CD, Gallick GF, Ellis, LM. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br. J. Cancer 2001; 84: 844-850.
54. Lu J, Ho CT, Ghai G, Chen KY. Differential effects of theaflavin monogallates on cell growth, apoptosis, an Cox-2 gene expression in cancerous versus normal cells. Cancer Res. 2000; 60: 6465-6471.
55. Liang YC, Chen YC, Lin YL, Lin-Shiau SY, Ho CT, Lin JK. Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3′-digallate. Carcinogenesis 1999; 20: 733-376.
56. Chung JY, Huang C, Meng X, Dong Z, Yang CS. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res. 1999; 59: 4610-4617.
57. Lin JK, Liang YC, Lin-Shiau SY. Cancer Chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem. Pharmacol. 1999; 58: 911-915.
58. Landau JM, Wang Z-Y, Yang G-Y, Ding W, Yang CS. Inhibition of spontaneous formation of lung tumors and rhabdomyo-sarcomas in A/J mice by black and green tea. Carcinogenesis 1998; 19: 501-507.
59. Shimkin MB, Weisburger JH, Weisburger EK, Gubareff N, Suntzeff V. Bioassay of 29 alkylating chemicals by the pulmonary-tumor response in strain A mice. J. Natl. Cancer Inst. 1966; 36: 915-935.
60. Yang GY Liu Z, Seril DN, Liao J, Ding, Kim S, Bondoc F, Yang CS. Black tea constituents, theaflavins, inhibit 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice. Carcinogenesis 1997; 28: 2361-2365.
61. Lu YP, Lou YR, Xie JG, Yen P, Huang MT, Conney AH. Inhibitory effect of black tea on the growth of established skin tumors in mice: effects on tumor size, apoptosis, mitosis and bromodeoxyuridine incorporation into DNA. Carcinogenesis 1997; 18: 2163-2169.
62. Liang YC, Lin-Shiau SY, Chen CF, Lin JK. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J. Cell Biochem. 1997; 67: 55-65.
63. Okabe S, Suganuma M, Hayashi M, Sueoka E, Komori A, Fujiki H. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn. J. Cancer Res. 1997; 88: 639-643.
64. Hayashi R, Luk H, Horio DT, Dashwood RH. Inhibition of apoptosis in colon tumors induced in the rat by 2-amino-3-methylimidazo(4,5-f]quinoline. Cancer Res. 1996; 56: 4307-4310.
65. Conney AH, Lu Y-P, Lou Y-R, Huang M-T. Inhibitory effects of tea and caffeine on UV-induced carcinogenesis: relationship to enhanced apoptosis and decreased tissue fat. Eur. J. Cancer Prev. 2002; 11 (suppl 2): S28-S36.
66. Zhang G, Miura Y, Yagasaki K. Induction of apoptosis and cell cycle arrest in cancer cells by in vivo metabolites of teas. Nutr. Cancer 2000; 38: 265-273.
67. Kondo T, Ohta T, Igura K, Hara Y, Kaji K. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Lett. 2002; 180: 139-144.
68. Hirose M, Nishikawa A, Shibutani M, Imai T, Shirai T. Chemo-prevention of heterocyclic amine-induced mammary carcinogenesis in rats. Environ. Mol. Mutagen. 2002; 39: 271-278.
69. Ahmad N, Feyes DK, Nieminen A-L, Agarwal R, Mukhtar H. Green tea constituents epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 1997; 89: 1881-1886.
70. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA 2001; 98: 10350-10355.
71. Hara Y. Green Tea: Health Benefits and Applications. New York, Marcel Dekker, Inc. 2001, pp. 1-252.
72. Hasaniya N, Youn K, Xu M, Hernaez J, Dashwood R. Inhibitory activity of green and black tea in a free radical-generating system using 2-amino-3-methylimidazo[4,5-f]quinoline as substrate. Jpn. J. Cancer Res. 1997; 88: 553-558.
73. Mukhtar H, Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am. J. Clin. Nutr. 2000; 71 (suppl 6): 1703S-1704S.
74. Chiueh CC, editor. Reactive oxygen species from radiation to molecular biology. Ann. NY. Acad. Sci. 2000; 899: 1-426.
75. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000; 21: 361-370.
76. Uchida K, Shiraishi M, Naito Y, Torrii Y, Nakamura Y, Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. J. Biol. Chem. 1999; 274: 2234-2242.
77. Adler V, Yin Z, Tew KD, Ronai Z. Role of redox potential and reactive oxygene species in stress signaling. Oncogene 1999; 18: 6104-6111.
78. Dalton TP, Shertzer HG, Puga A. Regulation of gene expression by reactive oxygen. Ann. Rev. Pharmacol. Toxicol. 1999; 39: 67-101.
79. Santana-Rios G, Omer GA, Amantana A, Provost C, Wu SY, Dashwood RH. Potent antimutagenic activity of white tea in comparison with green tea in the Salmonella assay. Mutat. Res. 2001; 495: 61-74.
80. Santana-Rios G, Orner GA, Xu M, Izquierdo-Pulido M, Dashwood RH. Inhibition by white tea of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced colonic aberrant crypts in the F344 Rat. Nutr. Cancer 2001; 41: 98-103.
81. Dashwood RH. Modulation of heterocyclic amine-induced mutagenicity and carcinogenicity: An 'A-to-Z' guide to chemopreventive agents, promoters, and transgenic models. Mutat. Res. 2002; 511: 89-112.
82. Leenen R, Roodenburg AJ, Tijburg LB, Wiseman SA. A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur. J. Clin. Nutr. 2000; 54: 87-92.
83. van het Hof Kh, Kivits GA, Weststrate JA, Tijburg LB. Bioavailability of catechins from tea: the effect of milk. Eur. J. Clin. Nutr. 1998; 52: 356-359.
84. Weisburger JH. Cover Legend: Tea. Cancer Research 1998; 58 (September 15).
85. Greenwald P, McDonald SS, Anderson DE. An evidence-based approach to cancer prevention clinical trials. Eur. J. Cancer Prev. 2002; 11 (suppl 2): S43-S47.